Kojima, Marenori http://orcid.org/0000-0001-7637-4867
Suzuki, Katsuya
Takeshita, Masaru
Ohyagi, Masaki
Iizuka, Mana
Yamane, Humitsugu
Koga, Keiko
Kouro, Taku
Kassai, Yoshiaki
Yoshihara, Tomoki
Adachi, Ryutaro
Hashikami, Kentarou
Ota, Yuichiro
Yoshimoto, Keiko
Kaneko, Yuko
Morita, Rimpei
Yoshimura, Akihiko
Takeuchi, Tsutomu http://orcid.org/0000-0003-1111-8218
Article History
Received: 5 March 2022
Accepted: 26 April 2023
First Online: 9 May 2023
Competing interests
: K.K., T.K., Yo.K., T.Y., R.A., and K.H. are employees of Takeda Pharmaceutical Company Limited. This study was performed as part of a research collaboration between Keio University and Takeda Pharmaceutical Company Limited. Authors M.K., K.S., M.T., K.K., T.K., Yo.K., T.Y., R.A., A.Y. and T.T. hold the patent (Patent # WO2022/075474) for anti-human-TIGIT agonistic antibody. The remaining authors declare no competing interests.